23andMe breach targeted Chinese, Jewish populations
A new lawsuit accuses 23andMe of failing to protect the privacy of customers whose data were exposed during a breach last year. It notes that Chinese and Ashkenazi Jewish profile…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hey there. Today, we discuss how Medicaid might pay for the costly but potentially curative sickle cell gene therapies, as well as the shocking lawsuit that outlines a data breach at 23andMe that targets Chinese and Jewish customers.
What's Your Reaction?
